Page last updated: 2024-08-17

1,4-dihydroxyanthraquinone and 1,2,5,8-tetrahydroxy anthraquinone

1,4-dihydroxyanthraquinone has been researched along with 1,2,5,8-tetrahydroxy anthraquinone in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Czarny, A; Frackowiak, A; Gancarz, R; Gaweł, W; Skibiński, P; Zaczyńska, E1
Inui, K; Kanamitsu, K; Katayama, W; Kitakami, R; Mizuguchi, M; Nakagawa, S; Nakagawa, Y; Okada, T; Sawai, Y; Toyooka, N; Yokoyama, T1
Lefin, R; Petzer, A; Petzer, JP1

Reviews

1 review(s) available for 1,4-dihydroxyanthraquinone and 1,2,5,8-tetrahydroxy anthraquinone

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000

Other Studies

3 other study(ies) available for 1,4-dihydroxyanthraquinone and 1,2,5,8-tetrahydroxy anthraquinone

ArticleYear
Synthesis of glycoside derivatives of hydroxyanthraquinone with ability to dissolve and inhibit formation of crystals of calcium oxalate. Potential compounds in kidney stone therapy.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Animals; Anthraquinones; Calcium Oxalate; Cell Line; Glycosides; Humans; Kidney Calculi; Mice; Molecular Structure; Solubility

2010
Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.
    Bioorganic & medicinal chemistry, 2021, 08-15, Volume: 44

    Topics: Amyloid Neuropathies, Familial; Anthraquinones; Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Xanthones

2021
Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
    Bioorganic & medicinal chemistry, 2022, 01-15, Volume: 54

    Topics: Anthraquinones; Dose-Response Relationship, Drug; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenothiazines; Structure-Activity Relationship

2022